Sanofi (NASDAQ:SNY) will invest at least $20B in the U.S. through 2030 focusing on research and manufacturing, the company ...

The U.S. Food and Drug Administration ((FDA)) on Saturday approved the COVID-19 vaccine developed by Gaithersburg, Maryland-based biotech Novavax (NASDAQ:NVAX). Accordingly, the protein-based shot, ...

Sanofi has scrapped its collaboration with IGM Biosciences, eliminating the biotech’s l | Sanofi has scrapped its ...

Sanofi also confirmed the expectation of a strong ... and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...

while putting sustainability and social responsibility at the center of our ambitions. Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY.

A federal jury in Delaware has awarded Regeneron (NASDAQ:REGN) more than $400M in damages after finding that Amgen ...

The Department of Attorney General of Hawaii announced that Bristol-Myers Squibb (NYSE:BMY) and three units of Sanofi (NASDAQ ...

Moody’s Ratings has upgraded the long-term issuer rating and senior unsecured ratings of Sanofi (NASDAQ:SNY) from A1 to Aa3.

The French drugmaker, one of the world's largest vaccine makers and a leader in anti-inflammatory drugs, said on Wednesday it ...

Sanofi to invest $20 billion in the US by 2030, boosting R&D and expanding domestic manufacturing capacity. Investment aims to create high-paying jobs and strengthen the US supply chain through ...

Sanofi today announces its intention to invest at least $20 billion in the United States through 2030. The expected investment includes a significant increase in research and development spending and ...